What is the current Global Geriatric Medicines Market size?

The Global Geriatric Medicines Market is projected to register a CAGR of greater than 6.5% during the forecast period (2024-2029) Read More

Who are the key players in Global Geriatric Medicines Market?

Endo Pharmaceuticals Inc, Merck & Co Inc, AstraZeneca PLC, Pfizer Inc and Allergan Inc are the major companies operating in the Global Geriatric Medicines Market. Read More

Which is the fastest growing region in Global Geriatric Medicines Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Geriatric Medicines Market?

In 2024, the North America accounts for the largest market share in Global Geriatric Medicines Market. Read More

What years does this Global Geriatric Medicines Market cover?

The report covers the Global Geriatric Medicines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Geriatric Medicines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Geriatric Medicines Market

Geriatric Medicines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Geriatric Medicines Market is segmented by Therapeutic Category (Analgesics, Antibiotics, Antihypertensives, Antidepressants, and Other Therapeutic Categories), End-Users (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Geriatric Medicines Industry Overview

The geriatric medicines market is fragmented and competitive in nature due to the presence of many companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Endo Pharmaceuticals Inc., Merck & Co. Inc., Abbott Laboratories Inc., Pfizer Inc., AbbVie (Allergan Inc.), Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., AstraZeneca PLC, F. Hoffmann-La Roche AG, Octapharma AG, Novartis AG, Sanofi SA, and Boehringer Ingelheim GmbH.